Page last updated: 2024-09-04

cinacalcet and Chronic Kidney Failure

cinacalcet has been researched along with Chronic Kidney Failure in 276 studies

Research

Studies (276)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	120 (43.48)	29.6817
2010's	142 (51.45)	24.3611
2020's	14 (5.07)	2.80

Authors

Authors	Studies
Christopoulos, A; Conigrave, AD; Davey, AE; Leach, K; Sexton, PM; Valant, C	1
Ahmad, A; Alkhalili, E; Alvarado, L; Dwivedi, A; Hechanova, A; Lerma, R; Nwosu, A; Payan-Schober, F; Sharma, N	1
Ahn, JB; Mathur, A; McAdams-DeMarco, M; Segev, DL; Sutton, W; Zeiger, MA	1
Chertow, GM; Lenihan, CR; Liu, S; Montez-Rath, ME; Wang, AX	1
Agafonova, E; Jankovic, L; Morosetti, M; Pryshlyak, I; Zappalà, L	1
Cheung, SC; Lang, BH; Lo, WK; Tang, TK; Wang, AY; Yau, YY	1
Barreto, FC; Bucharles, SGE; Riella, MC	1
Ayach, T; El-Husseini, A; Elyamny, M; Kakani, E	1
Geer, J; Joseph, C; Juarez-Calderon, M; Shah, S; Srivaths, PR; Swartz, SJ	1
Li, H; Lu, X; Song, J; Wang, S; Yu, L; Zu, Y	1
Bacchetta, J; Bernardor, J; Büscher, A; Dello Strologo, L; Genc, G; John, U; Krupka, K; Oh, J; Schmitt, CP; Sellier-Leclerc, AL; Tönshoff, B; Weitz, M; Zirngibl, M	1
Hur, C; Kuo, JH; Lee, JA; McManus, C; Oh, A	1
Fomenko, MS; Pavlov, AA; Sheng, Z; Shilenko, PA; Shneider, YA; Sun, Y; Tian, B; Tsoi, MD; Wan, P; Xu, T; Yao, L	1
Ikeda, M; Maruyama, Y; Matsuo, N; Morishita, M; Nakao, M; Ohkido, I; Tanno, Y; Yokoo, T	1
Belozeroff, V; Chonchol, M; Danese, MD; Desai, P; Gleeson, M; Lin, TC; Lubeck, D; Martin, K	1
Ahn, JB; Mathur, A; McAdams-DeMarco, M; Prescott, JD; Segev, DL; Sutton, W; Zeiger, MA	1
Alderson, H; Bubtana, A; Chinnadurai, R; Chrysochou, C; Eddington, H; Erekosima, I; Green, D; Hegarty, J; Hutchison, A; Ibrahim, ST; Kalra, PA	1
Fligor, SC; Hamaguchi, R; James, BC; Li, C; William, J	1
Emoto, M; Inaba, M; Ishimura, E; Kabata, D; Machiba, Y; Mori, K; Morioka, F; Nakatani, S; Nishide, K; Okuno, S; Shoji, S; Tsuda, A; Uedono, H; Yamakawa, T	1
de Borst, MH; Dulfer, RR; Engelsman, AF; Kruijff, S; van der Plas, WY; van Ginhoven, TM; Vogt, L	1
Hernández, AM; Llorente, S; Parrilla, P; Ríos, A; Rodríguez, JM; Ruiz, J	1
Friedl, C; Kramar, R; Mann, JFE; Pilz, S; Reibnegger, G; Rosenkranz, AR; Zitt, E	1
Block, GA; Chertow, GM	1
Agharazii, M; Bellemare, PL; Desmeules, S; Fortier, C; Gaudreault, V; Lebel, M; Mac-Way, F; Marquis, K; Poulin, A	1
Bradbury, BD; Brookhart, MA; Dluzniewski, PJ; Kshirsagar, A; Reams, D; Walsh, L	1
Fuse, M; Kada, S; Takada, D; Tsukamoto, T; Yanagita, M	1
Fyssa, L; Goumenos, DS; Ntrinias, T; Papachristou, E; Papasotiriou, M; Savvidaki, E; Zavvos, V	1
Ohno, Y; Oshima, J; Otsuka, K	1
Cannavò, R; Cestone, G; Cirillo, L; Cutruzzulà, R; Dattolo, PC; Errichiello, C; Gallo, P; Gregori, M; Mehmetaj, A; Sorrentino, A	1
Rroji, M; Spasovski, G	1
Bednarski, D; Grzegorzewska, AE; Jagodziński, PP; Mostowska, A; Świderska, M	1
Baker, D; Callahan, RE; Czako, PF; Lloyd, LR; Nagar, S; Sevak, S	1
Chertow, GM; Decker, BS; Edenberg, HJ; Foroud, TM; Long, J; Moe, SM; Schwantes-An, TL; Vatta, M; Wetherill, L; Xuei, X	1
Au, E; Elder, GJ; Gock, H; Gray, NA; Hawley, CM; Holt, SG; Kirkland, GS; Krishnasamy, R; Mainra, R; Maslen, S; Nelson, CL; Oliver, V; Rajaram, Y; Ruderman, I; Talaulikar, GS; Toussaint, ND	1
Abitbol, CL; Arenas Morales, AJ; Chandar, J; DeFreitas, MJ; Freundlich, M; Katsoufis, CP; Seeherunvong, W; Zilleruelo, G	1
Delbridge, LW; Dulfer, RR; Engelsman, AF; Kruijff, S; van der Plas, WY; van Ginhoven, TM; Vriens, MR	1
Delbridge, LW; Engelsman, AF; Kruijff, S; Mather, A; Pollock, C; Sidhu, SB; Sywak, MS; Umakanthan, M; van der Plas, WY; Waugh, D	1
Belozeroff, V; Bhatt, N; Fuller, DS; Morgenstern, H; Pisoni, RL; Robinson, BM; Rubin, RJ; Xing, S; Yehoshua, A	1
Chertow, GM; Franchetti, Y; Liu, S; Long, J; Mahnken, JD; Nolin, TD; Prokopienko, AJ; Stedman, MR; Stubbs, JR; West, RE	1
Bhargava, R; Brenchley, P; Hann, M; Hurst, H; Hutchison, AJ; Kalra, PA	1
Dumrongpisutikul, N; Eiam-Ong, S; Jakchairoongruang, K; Praditpornsilpa, K; Singhan, W; Susantitaphong, P; Susomboon, T; Vadcharavivad, S	1
Abbachi, F; Abouchacra, S; Bernsen, R; Chaaban, A; Gebran, N; Haq, N; Hassan, M; Khan, I	1
Inoshita, N; Marui, Y; Nakamura, M; Ohashi, K; Sumida, K; Takaichi, K; Tanaka, K; Tomikawa, S; Ubara, Y	2
Matuszkiewicz-Rowińska, J; Staszków, M; Wojtaszek, E; Żebrowski, P	1
Flechner, SM; Seager, CM; Srinivas, TR	1
Ketteler, M; Khan, SS; Marshall, TS; Schumock, GT; Sharma, A	1
Belozeroff, V; Campbell, JD; Chiroli, S; Lee, A; Tseng, S	1
Kilpatrick, RD; Liu, J; Newsome, BB; Nieman, K; Solid, CA; St Peter, WL; Zaun, D	1
Burnier, M; Forni Ogna, V; Pruijm, M; Tousset, E; Wuerzner, G; Zweiacker, C	1
Aldi, M; Cantelli, S; Gaddoni, G; Misciali, C; Odorici, G; Patrizi, A; Savoia, F; Tampieri, E; Tampieri, G	1
Albero-Molina, MD; Álvarez-Avellán, L; del Pozo-Fernández, C; López-Menchero-Martínez, R; Sánchez-Rodríguez, L	1
Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; London, GM; Mahaffey, KW; Modafferi, DM; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC	1
Bellasi, A; Floege, J; Goodman, W; Pétavy, F; Raggi, P; Reiner, M	1
Barros, X; Torregrosa, JV	1
Flanagan, D; Mancini, M	1
Fukagawa, M; Kakuta, T; Kanai, G; Komaba, H; Sawada, K; Suzuki, H; Takahashi, H; Takahashi, Y; Tatsumi, R	1
Borges, L; Cássio, I; Dias, E; Rosa, P	1
Ayav, C; Brunaud, L; Erpelding, ML; Filipozzi, P; Frimat, L; Kessler, M	1
Abdalla, S; Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC	1
Ballinger, AE; Craig, JC; Nistor, I; Palmer, SC; Strippoli, GF	1
Brandenburg, VM; Cozzolino, M; Mazzaferro, S	1
Abdalla, S; Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; London, GM; Mahaffey, KW; Moe, SM; Parfrey, PS; Wheeler, DC	1
Block, GA; Chertow, GM; Correa-Rotter, R; Dehmel, B; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Moe, SM; Parfrey, PS; Wheeler, DC	1
Eriguchi, R; Fujimi, S; Kitazono, T; Ooboshi, H; Suehiro, T; Taniguchi, M; Tokumoto, M; Toyonaga, J; Tsuruya, K; Yamada, S	1
Buerkert, J; Cooper, K; Da Roza, G; Goodman, W; Gurevich, K; Reiner, M; Sprague, SM; Wetmore, JB	1
Bradbury, BD; Collins, AJ; Do, T; Liu, J; Lowe, KA; Nieman, KM; St Peter, WL; Yusuf, AA	1
Chertow, GM; Floege, A; Floege, J; Kubo, Y; Parfrey, PS	1
Biggar, PH; Ketteler, M	1
Buerkert, J; Cooper, K; Da Roza, G; Goodman, W; Gurevich, K; Reiner, M; Sprague, S; Wetmore, JB	1
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y	1
Lorenzoni, V; Trieste, L; Turchetti, G	1
Anker, SD; de Francisco, AL; Drüeke, TB; Floege, J; Froissart, M; Gillespie, IA; Gioni, I; Kubo, Y; Wheeler, DC	1
Afsar, B; Agca, E; Turk, S	1
Ballarín, J; Bover, J; Cozzolino, M; daSilva, I; del Carpio, J; Lescano, P; Ruiz-García, C; Ureña, P	1
Duarte-Gallego, V; Esteve Simo, V; Fulquet Nicolas, M; Macias-Toro, J; Martínez Calvo, G; Moreno-Guzmán, F; Pou Potau, M; Ramírez-de Arellano Serna, M; Saurina Sole, A	1
Aronova, A; Ayav, C; Brunaud, L; Filipozzi, P; Frimat, L; Kessler, M; Ngueyon Sime, W; Nomine-Criqui, C; Zarnegar, R	1
Bradbury, BD; Brookhart, MA; Dluzniewski, PJ; Do, TP; Kshirsagar, AV; Reams, BD; Yue, SV	1
Berliner, A; Jaar, BG; McMahon, BA; Novick, T	1
Belozeroff, V; Briggs, AH; Chertow, GM; Dehmel, B; Graham, CN; Parfrey, PS	1
Micozkadioglu, H; Nursal, GN; Ozelsancak, R; Torun, D; Yigit, F; Yildiz, I	1
Bravo, J; Castilla, YA; Esteban, MA; Esteban, RJ; Fernández-Castillo, R; García-Valverde, M; Nozal-Fernández, G; Orellana, JM	1
Chen, N; Ding, X; Hou, F; Jiang, G; Li, X; Liu, H; Mei, C; Qian, J; Wang, L; Wang, M; Wang, N; Yu, X; Zuo, L	1
Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Kurita, N; Kurokawa, K; Onishi, Y; Yokoyama, K	1
Abdalla, S; Chertow, GM; Montez-Rath, ME; Parfrey, PS	1
Chertow, GM; Kim, SM; Leonard, MB; Long, J; Montez-Rath, ME; Norton, JA	1
Buttar, RS; Coco, M; Melamed, ML	1
Bensink, ME; Bradbury, BD; Brunelli, SM; Cooper, K; Dluzniewski, PJ; Sibbel, S	1
Bellasi, A; Cozzolino, M; Di Iorio, B; Molony, D; Russo, D	1
de Borst, MH; Engelsman, AF; Kruijff, S; Meijer, K; Özyilmaz, A; Pol, RA; van Dam, GM; van der Horst-Schrivers, AN; van der Plas, WY	1
Akizawa, T; Fukagawa, M; Fukuhara, S; Fukuma, S; Ito, K; Matsushita, K; Tanaka, M; Yoshida, K	1
Bockenhauer, D; El-Desoky, SM; Kari, JA; Sawan, ZA; Shalaby, MA	1
Aitken, E; Al-Moasseb, Z	1
Arampatzis, S; Bachtler, M; Block, GA; Chertow, GM; Floege, J; Jahnen-Dechent, W; Ma, X; Parfrey, P; Pasch, A; Smith, ER	1
Block, GA; Bushinsky, DA; Cheng, S; Chertow, GM; Cunningham, J; Dehmel, B; Drueke, TB; Ketteler, M; Kewalramani, R; Martin, KJ; Moe, SM; Patel, UD; Silver, J; Sun, Y; Wang, H	1
Evenepoel, P	1
Bonfigli, F; Giansante, C; Gottardi, C; Padovan, C; Trevisan, G; Ulessi, B	1
Covit, A; Pepe, J; Shastri, J; Sherman, RA; Tran, A	1
Bahner, U; Brandl, M; Nies, C; Schmidt-Gayk, H	1
Cointault, O; Durand, D; Esposito, L; Gandia, P; Gennero, I; Guitard, J; Kamar, N; Lavayssière, L; Rostaing, L; Spataru, L	1
Clark, OH; Evenepoel, P; Triponez, F; Vanrenthergem, Y	1
Sane, DC	1
Raymond, CB; Wazny, LD	1
Kebig, A; Mohr, K	1
Asensio, C; Bover, J; Carter, D; Dellanna, F; Gross, P; Jehle, PM; Sánchez González, MC; Sanz, D; Schaefer, RM; Zani, V	1
Alvarez-Ude, F; Arenas, MD; Gil, MT; Gutiérrez, MD; Malek, T; Moledous, A; Salinas, A	1
Akizawa, T; Iwasaki, M; Koshikawa, S; Shigematsu, T; Tsukamoto, Y; Uchida, E	1
Borchhardt, KA; Haas, M; Heinzl, H; Hörl, WH; Mayerwöger, E; Sunder-Plassmann, G	1
Hasegawa, T; Hosoya, T; Nakano, H; Nakayama, M; Okazaki, M; Takeguchi, F; Terawaki, H	1
Kawata, T; Nagano, N; Wada, M	1
Akizawa, T	1
Drüeke, TB	3
Tahara, H	1
Matsuoka, S; Sato, T; Tominaga, Y; Uno, N	1
Fujii, M; Maeda, K; Mizutani, R; Myochin, H; Narita, M; Ohbayashi, T; Tsuruta, Y	1
Akizawa, T; Ito, A; Kurihara, S; Tsukamoto, Y; Yajima, A	1
Fukagawa, M; Komaba, H	1
Drüeke, TB; Ritz, E	1
Abboud, HE; Albizem, MB; Block, GA; Charytan, C; Chonchol, M; de Francisco, AL; Jolly, S; Kaplan, M; Kubo, Y; Locatelli, F; Mix, TC; Roger, SD; Sarkar, S	1
Arko, C; Block, GA; Li, Q; Liu, J; Nieman, K; Persky, M; St Peter, WL	1
Kalantar-Zadeh, K; Kovesdy, CP	1
Barsotti, G; Meola, M; Petrucci, I	1
Aladrén Regidor, MJ	1
Alonso, M; Andrés, E; Ballarín, J; Bover, J; Canal, C; Farré, N; Olaya, MT; Quílez, B	1
Filson, J; Nguyen, TV	1
Aguilar, A; Andrés, E; Baas, J; Ballarin, J; Bover, J; Canal, C; Farré, N; Lloret, MJ; Marco, H; Olaya, M; Reyes, J; Trinidad, P	1
Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Macário, F; Maduell, F; Messa, P; Pontoriero, G; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ	1
Ashman, N; Baños, A; Bencova, V; Fouque, D; Jacobson, SH; Leavey, S; Malberti, F; Os, I; Rix, M; Ryba, M; Saha, H; Ureña, P; Vervloet, M; Zani, V; Zitt, E	1
Bacchetta, J; Cochat, P; Morel, Y; Nicolino, M; Plotton, I; Ranchin, B; Vial, T	1
Brandenburg, V; Cozzolino, M	1
Cannata-Andía, JB; Fernández-Martín, JL	1
Harris, R; Padhi, D	1
Yokoyama, K	1
Fukagawa, M; Suzuki, M	1
Fukagawa, M; Komaba, H; Nakai, K	1
Hirukawa, T; Kakuta, T; Kanai, G; Saito, A; Sato, A; Sawaya, A; Tanaka, R	1
Burren, C; Dudley, J; Inward, C; McGraw, M; Platt, C; Saleem, MA; Tizard, J	1
Krebill, R; Liu, S; Menard, R; Quarles, LD; Wetmore, JB	1
Block, GA; Chertow, GM; Csiky, B; Dehmel, B; Downey, G; Floege, J; Goodman, WG; Lopez, N; Moustafa, M; Naso, A; Nossuli, K; Raggi, P; Torres, PU	1
Cannata-Andía, JB; López-Hernández, F; Rodriguez-García, M; Rodríguez-Puyol, D; Román-García, P; Tuñón-le Poultel, D	1
Chazot, C; Deleaval, P; Hurot, JM; Jean, G; Lorriaux, C; Mayor, B; Terrat, JC; Vanel, T; Vovan, C	1
Chou, H; Ichii, M; Inaba, M; Ishimura, E; Kato, Y; Maekawa, K; Nagasue, K; Nishizawa, Y; Okuno, S; Tsuboniwa, N; Yamakawa, T	1
Bossola, M; Castagneto, M; De Gaetano, A; Di Stasio, E; Giordano, A; Luciani, G; Maresca, G; Vulpio, C; Zagaria, L	1
Almirall, J; Castañé, E; Gallardo, X	1
Block, GA; Brillhart, S; Liu, J; Nieman, K; Persky, M; Smits, G; St Peter, WL; Zaun, D	1
Sulková, SD; Válek, M	1
Ahlenstiel, T; Ariceta, G; Bak, M; Bakkaloglu, SA; Borzych, D; Chua, A; Ha, IS; Hari, P; Klaus, G; Lipka, M; Lopez, L; Ozaltin, F; Printza, N; Rees, L; Schaefer, F; Spizzirri, AP; Valles, PG; Vogel, A; Warady, BA; Yap, HK; Zambrano, P	1
Al Saran, K; Molhem, A; Sabry, A; Yehia, A	1
Ashman, N; Bencova, V; Dehmel, B; Fouque, D; Jacobson, SH; Malberti, F; Os, I; Petavy, F; Rix, M; Ryba, M; Saha, H; Ureña, P; Vervloet, M; Zitt, E	1
Dehmel, B; Fouque, D; Jacobson, SH; Pétavy, F; Rix, M; Ryba, M; Ureña Torres, P; Zitt, E	1
Almehmi, A; Lu, J; Pregenzer, M; Quarles, LD; Shireman, TI; Wetmore, JB	1
Chazot, C; Jean, G; Terrat, JC; Vanel, T	1
Erickson, KF; Winkelmayer, WC	1
Hirai, T; Nakashima, A; Takasugi, N; Yorioka, N	1
Chertow, GM; Csiky, B; Dehmel, B; Downey, G; Floege, J; Goodman, WG; Lopez, N; Moustafa, M; Naso, A; Nossuli, K; Raggi, P; Torres, PU	1
Floege, J; Groene, HJ; Mühlfeld, A; Seikrit, C	1
Braun, J; Reichel, H	1
Haller, H; Leitolf, H; Merkel, S; Schwarz, A	1
Cuxart Pérez, M; Picazo Sánchez, M; Sans Lorman, R; Sardà Borroy, C	1
Bayés, B; Bonet, J; Casals, M; Fernández-Crespo, P; López-Ayerbe, J; Romero, R	1
Arkouche, W; Attaf, D; Boumendjel, N; Cardozo, C; Cardozo, J; Fouque, D; Karaaslan, H; Laville, M; Lenz, A; Mpio, I; Pastural-Thaunat, M; Silou, J	1
Lewin, E; Olgaard, K; Silver, J	1
Okimoto, N; Oshiro, Y; Tanaka, H	1
Bravo Soto, J; Esteban de la Rosa, RJ; Fernández Castillo, R; Fernández Gallegos, R; Oliva, N; Vaquero, E	1
Al-Azmi, M; Al-Hilali, N; Hussain, N; Kawy, YA	1
Bonomini, M; Brancaccio, D; Cancarini, G; Cannella, G; Caruso, MR; Cascone, C; Costanzo, AM; Cozzolino, M; di Luzio Paparatti, U; Mazzaferro, S; Messa, P	1
Anstey, CM; Gray, NA; Hollett, PR; Krishnasamy, R; Vardesh, DL	1
Fujimori, A; Fukagawa, M; Koizumi, M; Komaba, H; Nakanishi, S	1
Bargman, JM; Battistella, M; Chan, CT; Richardson, RM	1
Plosker, GL	1
Kreuter, A; Scola, N	1
Baldwin, C; Farah, M; Kiaii, M; Leung, M; Levin, A; Taylor, P; Werb, R	1
Ichii, M; Inaba, M; Ishimura, E; Nishizawa, Y; Okuno, S; Shoji, S; Tsuboniwa, N; Yamakawa, K; Yamakawa, T	1
Martínez, AI; Milán, JA; Salgueira, M	1
Borrajo Prol, M; Camba Caride, M; Conde Rivera, O; Iglesias Lamas, E; López Alarcóon, W; Novoa Fernández, E; Santos Nores, J	1
Colloton, M; Davis, J; Henley, CM; Martin, D; Miller, G; Shatzen, E	1
Inoue, T; Kikuta, T; Sato, T; Suzuki, H; Tsuda, M; Uchida, K; Watanabe, Y	1
Block, GA; Bushinsky, DA; Chertow, GM; Goodman, WG; Knight, TG; Lu, ZJ; Xu, X	1
Allison, A; Drumheller, JC; Lockridge, R; McPhatter, L; Spiegel, DM	1
Fukagawa, M; Goto, S; Kakuta, T; Kamae, I; Komaba, H; Moriwaki, K; Taniguchi, M; Yamada, S	1
Block, GA; Chertow, GM; Correa-Rotter, R; Drueke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TC; Moe, SM; Parfrey, PS; Wheeler, DC	1
Hu, B; Hu, P; Lu, L; Qin, YH; Wang, J; Xuan, Q	1
Tse, MT	1
Jiang, W; Li, D; Shao, L; Xu, Y; Zhang, W; Zhou, H	1
Grzegorzewska, AE; Niepolski, L	1
Couttenye, MM; Janssen van Doorn, K; Van Noten, C; Vermander, E; Verpooten, GA; Vlayen, S	1
Bajo-Rubio, MA; De Sousa-Amorim, E; Del Peso-Gilsanz, G; Selgas-Gutiérrez, R	1
Bian, A; Ellis, CD; Hung, AM; Ikizler, TA; Plotnikova, NE; Shintani, A; Siew, ED; Sundell, MB	1
Brunet, P; Fouque, D; Réglier, JC; Touam, M; Ureña, P	1
Barros, X; Campistol, JM; Durán, CE; Paschoalin, RP; Torregrosa, JV	1
Sunder, S; Venkataramanan, K; Verma, H	1
Neal, B; Perkovic, V	1
Block, GA; Chertow, GM; Correa-Rotter, R; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TC; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC	1
Chen, J; Gu, Y; Hao, C; Li, H; Li, M; Ni, L; You, L; Zhang, Q	1
Chudek, J; Kocełak, P; Olszanecka Glinianowicz, M; Zelaźnicka, M	1
Bain, JH; Csongrádi, É; Fülöp, T; Hamrahian, M; Kanyicska, B; Pitman, KT	1
Chrul, S; Zwiech, R	1
Blaisdell, PW; Brenner, RM; Coburn, JW; Goodman, WG; Lindberg, JS; Liu, W; Martin, KJ; Moe, SM; Sprague, SM; Turner, SA	1
Adler, S; Bushinsky, DA; Liu, W; McCary, LC; Quarles, LD; Rosansky, SJ; Sherrard, DJ; Turner, SA	1
Franceschini, N; Joy, MS; Kshirsagar, A	1
Abu-Alfa, AK; Avram, MM; Block, GA; Braun, J; Cohen, RM; Coyne, DW; Cunningham, J; de Francisco, AL; Drüeke, TB; Evenepoel, P; Fournier, A; Goodman, WG; Hercz, G; Locatelli, F; Martin, KJ; McCary, LC; Messa, P; Moe, SM; Olson, KA; Suranyi, MG; Turner, SA; Zani, VJ	1
Curhan, G	1
Akizawa, T; Hishida, A; Kanamaru, M; Koshikawa, S; Nagashima, S; Ohashi, N; Togawa, A; Uchida, E; Uematsu, T	1
Alam, MG; Kumar, J; Owda, AK	1
Chanard, J; Ureña Torres, PA	1
Ureña Torres, P	2
Barman Balfour, JA; Scott, LJ	1
Moe, SM	1
Matuszkiewicz-Rowińska, J	1
Albizem, MB; Borah, MF; Clark, RV; Coburn, JW; Culleton, B; Guo, MD; Husserl, FE; Klassen, PS; Lindberg, JS; Roger, SD; Shapiro, WB; Wong, G	1
Nagano, N; Nemeth, EF	1
de Francisco, AL	1
González, EA; Martin, KJ; Wood, C	1
Chou, SY; Rothe, HM; Shapiro, WB; Sun, WY	1
Lindberg, JS	1
Byrnes, CA; Shepler, BM	1
Marti, HP; Schwarz, AA; Serra, AL; Wick, FH; Wüthrich, RP	1
Eisenberger, U; Frey, FJ; Kruse, AE; Mohaupt, MG	1
Adler, S; Albizem, MB; Bommer, J; Cunningham, J; Goodman, WG; Guo, MD; Moe, SM; Rosansky, SJ; Sprague, SM; Urena-Torres, P; Zani, VJ	1
Andrés, E; Ballarín, J; Barceló, P; Bover, J; Ortiz-Herbener, F	1
Chertow, GM; Cunningham, J; Danese, M; Klassen, P; Olson, K	1
Deray, G; Izzedine, H; Karie, S; Launay-Vacher, V	1
Cunningham, J	1
Anders, HJ	1
Dong, BJ	1
Innes, A; MacGregor, MS; MacKay, IG; Velasco, N	1
Imanishi, Y; Inaba, M	1
Torres, PU	1
Sułowicz, W	1
Ito, H; Kinugasa, E; Koiwa, F; Ogata, H	1
Fukagawa, M	1
Choukroun, G; Fournier, A; Massy, Z; Mazouz, H; Monge, M; Morinière, P; Oprisiu, R; Shahapuni, I; Westeel, PF	1
Delsignore, A; Hepp, U; Hersberger, M; Huber, AR; Savoca, R; Serra, AL; Wüthrich, RP	1
Ashfaq, A; Gitman, M; Singhal, PC	1
Bell, S; Casey, L; Chonchol, M; Parker, M; Spiegel, DM	1
Dorsch, O	1
Burkitt-Wright, E; Rustom, R; Sharma, A	1
Nagano, N	1
Gille, J; Kaufmann, R; Meissner, M	1
Fadem, SZ; Moe, SM	1
Fukagawa, M; Nakanishi, S	1
Anderson, R; D'Souza, R; Garside, R; Mealing, S; Pitt, M; Stein, K	1
Lauerwald, W; Unbehaun, R	1
Charra, B; Chazot, C; Jean, G	1
Hebert, K; Lazar, E; Poma, T; Stankus, N	1
Köstler, E; Wollina, U	1
Anderson, R; D'Souza, R; Garside, R; Mealing, S; Pitt, M; Roome, C; Snaith, A; Stein, K; Welch, K	1
Akiba, T	1
Colin Forfar, J; Tilling, L	1
Abbott, KC; Berbano, EP; Narayan, R; Neff, RT; Perkins, RM; Sawyers, ES; Vidal-Trecan, GM; Yeo, FE; Yuan, CM	1
James, SH; Lien, YH; Logan, JL; Peng, LW; Scott, KM	1
Palmer, AJ; Ray, JA; Valentine, WJ	1
Bergua, C; Cofán, F; Oppenheimer, F; Torregrosa, JV	1
Bubtana, AJ; Hutchison, AJ; Mitra, S; Mohammed, IA; Sekar, V	1
Bilezikian, JP; Martin, D; Wüthrich, RP	1
Bajo, MA; Codoceo, R; Del Peso, G; Díez, JJ; Gancedo, PG; Gil, F; Iglesias, P; Martinez-Ara, J; Miguel, JL; Sánchez, C; Selgas, R	1
Fukumoto, S	1
Giotta, N; Marino, A	1
Cohen, E	1
Burnier, M; Pruijm, MT; Santschi, V; Teta, D; Wuerzner, G	1
Comte, C; Dereure, O; Leray-Mouragues, H; Pallure, V	1
Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Locatelli, F; Macário, F; Maduell, F; Messa, P; Molemans, B; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ	1
Chattopadhyay, N; Mithal, A; Trivedi, R	1
Iseki, K	1
Negri, AL	1
Akiba, T; Akizawa, T; Iwasaki, M; Koshikawa, S; Tsukamoto, Y; Uchida, E	1
Limardo, M; Locatelli, F; Pontoriero, G	1
Baker, N; Charytan, C; Coburn, JW; Coyne, DW; Frazã O, JM; Goodman, WG; Kaplan, MR; Malluche, HH; McCary, LC; Monier-Faugere, MC; Turner, SA; Wang, G	1
Decleire, PY; Devogelaer, JP; Goffin, E	1
Coyne, DW	1
Drueckler, E; Fischer, DC; Haffner, D; Kundt, G; Muscheites, J; Wigger, M	1
de Francisco, AL; Palomar, R; Piñera, C	1
Barri, YM; Blaisdell, PW; Coburn, JW; Cohen, RM; Goodkin, DA; Goodman, WG; Hladik, GA; Liu, W; Turner, SA	1

Reviews

61 review(s) available for cinacalcet and Chronic Kidney Failure

Article	Year
Pathogenesis and management of vascular calcification in CKD and dialysis patients. Seminars in dialysis, 2019, Volume: 32, Issue:6 Topics: Calciphylaxis; Calcitriol; Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Comorbidity; Female; Humans; Incidence; Kidney Failure, Chronic; Male; Prognosis; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vascular Calcification; Vitamin D	2019
Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis. Kidney & blood pressure research, 2019, Volume: 44, Issue:6 Topics: Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Renal Dialysis; Survival Rate	2019
[Aortic valve replacement via J-shaped partial upper sternotomy: randomized trial, mid-term results]. Khirurgiia, 2020, Issue:7 Topics: Adult; Aged; Aortic Valve; Calcium-Regulating Hormones and Agents; Cinacalcet; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minimally Invasive Surgical Procedures; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Retrospective Studies; Sternotomy; Treatment Outcome	2020
Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, Nov-01, Volume: 32, Issue:11 Topics: Calcimimetic Agents; Cinacalcet; Combined Modality Therapy; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroidectomy; Postoperative Period; Quality of Life	2017
Calcimimetics versus parathyroidectomy: What is preferable? International urology and nephrology, 2018, Volume: 50, Issue:7 Topics: Administration, Oral; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroidectomy; Prognosis; Renal Dialysis; Risk Assessment; Treatment Outcome	2018
Management of hypercalcemia after renal transplantation. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Nov-13, Volume: 33, Issue:6 Topics: Algorithms; Bone Resorption; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Renal Dialysis; Vitamin D	2013
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. The Cochrane database of systematic reviews, 2014, Issue:12 Topics: Calcimimetic Agents; Calcium; Cardiovascular Diseases; Cause of Death; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis	2014
Calcific uremic arteriolopathy: a call for action. Seminars in nephrology, 2014, Volume: 34, Issue:6 Topics: Antioxidants; Biomedical Research; Calciphylaxis; Cinacalcet; Diphosphonates; Humans; Kidney Failure, Chronic; Naphthalenes; Parathyroidectomy; Risk Factors; Thiosulfates; Vitamin K	2014
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet. Expert review of pharmacoeconomics & outcomes research, 2015, Volume: 15, Issue:4 Topics: Adult; Chelating Agents; Cinacalcet; Cost-Benefit Analysis; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphates; Vitamin D	2015
Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism. Clinical journal of the American Society of Nephrology : CJASN, 2016, Jan-07, Volume: 11, Issue:1 Topics: Calcimimetic Agents; Cinacalcet; Electrocardiography; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis; Vascular Calcification	2016
CKD-Mineral Bone Disorder in Stage 4 and 5 CKD: What We Know Today? Advances in chronic kidney disease, 2016, Volume: 23, Issue:4 Topics: Bicarbonates; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Fibroblast Growth Factor-23; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Renal Insufficiency, Chronic; Vitamin D	2016
Calcimimetics in chronic kidney disease: evidence, opportunities and challenges. Kidney international, 2008, Volume: 74, Issue:3 Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Molecular Mimicry; Naphthalenes; Receptors, Calcium-Sensing	2008
Surgical treatment of persistent hyperparathyroidism after renal transplantation. Annals of surgery, 2008, Volume: 248, Issue:1 Topics: Cinacalcet; Cryopreservation; Diagnostic Imaging; Disease Progression; Humans; Hypercalcemia; Hyperparathyroidism; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Monitoring, Intraoperative; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Thymectomy	2008
[Cinacalcet - an allosteric enhancer at the Ca2+-receptor]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:33 Topics: Calcium; Cinacalcet; Drug Monitoring; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Receptors, Calcium-Sensing; Renal Dialysis	2008
Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:1 Topics: Animals; Calcium; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Risk Assessment; Treatment Outcome; Vitamin D	2009
Update on the treatment of chronic kidney disease-mineral and bone disorder. Journal of renal care, 2009, Volume: 35 Suppl 1 Topics: Aluminum Compounds; Calcinosis; Calcium Carbonate; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet, Protein-Restricted; Dietetics; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Nephrology; Nutrition Assessment; Nutritive Value; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Vitamin D	2009
Calcimimetics in the chronic kidney disease-mineral and bone disorder. The International journal of artificial organs, 2009, Volume: 32, Issue:2 Topics: Bone Diseases; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes	2009
Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U". Clinical nephrology, 2009, Volume: 71, Issue:6 Topics: Calcium; Cinacalcet; Clinical Trials as Topic; Comorbidity; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Treatment Outcome; Vitamins	2009
Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride. Clinical pharmacokinetics, 2009, Volume: 48, Issue:5 Topics: Animals; Cinacalcet; Clinical Trials as Topic; Cytochrome P-450 Enzyme System; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes	2009
Management of mineral and bone disorder in chronic kidney disease: quo vadis? Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2009, Volume: 13 Suppl 1 Topics: Bone Diseases, Metabolic; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Vitamin D; Vitamins	2009
New therapies: calcimimetics, phosphate binders and vitamin D receptor activators. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:4 Topics: Bone Density Conservation Agents; Calcium; Chelating Agents; Child; Cinacalcet; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Glands; Phosphates; Polyamines; Protein Binding; Receptors, Calcitriol; Receptors, Calcium-Sensing; Sevelamer	2010
Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic. Nature reviews. Nephrology, 2011, Volume: 7, Issue:4 Topics: Cinacalcet; Graft Survival; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Nephrocalcinosis; Postoperative Complications; Transplantation, Homologous	2011
Cinacalcet: a pharmacoeconomic review of its use in secondary hyperparathyroidism in end-stage renal disease. PharmacoEconomics, 2011, Volume: 29, Issue:9 Topics: Calcium; Cinacalcet; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis	2011
Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease. International journal of biological sciences, 2012, Volume: 8, Issue:5 Topics: Animals; Calcimimetic Agents; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Endothelium, Vascular; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Kidney Transplantation; Male; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Insufficiency, Chronic; Sevelamer; Vascular Calcification; Vitamin D; Vitamin D Deficiency	2012
The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis. Endocrine, 2013, Volume: 43, Issue:1 Topics: Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcification, Physiologic; Calcimimetic Agents; Calcium, Dietary; Chelating Agents; Cinacalcet; Combined Modality Therapy; Dietary Supplements; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Peritoneal Dialysis; Phosphates; Randomized Controlled Trials as Topic; Renal Dialysis; Vitamin D	2013
[Calcimimetic drugs in stage 3-5 chronic kidney disease]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2012, Volume: 32, Issue:190 Topics: Calcimimetic Agents; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes	2012
Effects and safety of calcimimetics in end stage renal disease patients with secondary hyperparathyroidism: a meta-analysis. PloS one, 2012, Volume: 7, Issue:10 Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Odds Ratio; Patient Safety; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Treatment Outcome	2012
[Cinacalcet therapy and cardiovascular risk in hemodialysis patients]. Postepy higieny i medycyny doswiadczalnej (Online), 2012, Oct-22, Volume: 66 Topics: Atherosclerosis; Cardiovascular Diseases; Causality; Cinacalcet; Comorbidity; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Risk Factors; Vascular Calcification	2012
Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism. Expert opinion on investigational drugs, 2003, Volume: 12, Issue:8 Topics: Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Receptors, Cell Surface	2003
Calcimimetics versus vitamin D: what are their relative roles? Blood purification, 2004, Volume: 22, Issue:1 Topics: Calcitriol; Cinacalcet; Clinical Trials as Topic; Drug Synergism; Ergocalciferols; Humans; Hydroxycholecalciferols; Hypercalcemia; Hyperparathyroidism, Secondary; Intestinal Absorption; Kidney Failure, Chronic; Liver; Naphthalenes; Phosphates; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D; Vitamin D Deficiency	2004
Cinacalcet hydrochloride. Drugs, 2005, Volume: 65, Issue:2 Topics: Animals; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Neoplasms	2005
Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means. Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:3 Topics: Animals; Child; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis	2005
[New aspects in the management of renal osteodystrophy]. Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 112 Spec No Topics: Calcinosis; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Controlled Clinical Trials as Topic; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phosphates; Polyamines; Polyethylenes; Sevelamer	2004
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics. Journal of pharmacological sciences, 2005, Volume: 97, Issue:3 Topics: Aniline Compounds; Animals; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Models, Biological; Molecular Structure; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Propylamines; Rats; Receptors, Calcium-Sensing	2005
Secondary hyperparathyroidism: review of the disease and its treatment. Clinical therapeutics, 2004, Volume: 26, Issue:12 Topics: Calcium; Cinacalcet; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Renal Dialysis	2004
Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease. Kidney international. Supplement, 2005, Issue:95 Topics: Aniline Compounds; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phenethylamines; Propylamines; Vitamin D	2005
Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis. Pharmacotherapy, 2005, Volume: 25, Issue:5 Topics: Cinacalcet; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis	2005
[New therapeutic strategies in secondary hyperparathyroidism on dialysis (II): vitamin D analogues and calcium-mimetics]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25 Suppl 2 Topics: Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Calcium; Cinacalcet; Diphosphonates; Drug Therapy, Combination; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Renal Dialysis; Retrospective Studies; Teriparatide; Transforming Growth Factor beta; Vitamin D	2005
Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney international, 2005, Volume: 68, Issue:4 Topics: Adult; Aged; Cardiovascular Diseases; Cinacalcet; Female; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors	2005
[Management of secondary hyperparathyroidism]. Clinical calcium, 2005, Volume: 15 Suppl 1 Topics: Aniline Compounds; Calcinosis; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Design; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phenethylamines; Phosphorus; Polyamines; Practice Guidelines as Topic; Propylamines; Receptors, Calcium-Sensing; Sevelamer; Vascular Diseases; Vitamin D	2005
[Chronic kidney disease]. Medizinische Klinik (Munich, Germany : 1983), 2005, Nov-15, Volume: 100, Issue:11 Topics: Acidosis; Adult; Anemia, Aplastic; Cardiovascular Diseases; Cinacalcet; Disease Progression; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Kidney Transplantation; Multicenter Studies as Topic; Naphthalenes; Parathyroid Hormone; Practice Guidelines as Topic; Risk Factors	2005
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Clinical therapeutics, 2005, Volume: 27, Issue:11 Topics: Animals; Area Under Curve; Calcium; Cinacalcet; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Half-Life; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis	2005
[Secondary hyperparathyroidism]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Jun-28, Volume: Suppl 2 Topics: Adsorption; Blood Vessels; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diagnosis, Differential; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intralesional; Kidney Failure, Chronic; Naphthalenes; Osteitis; Parathyroidectomy; Phosphorus; Prognosis; Renal Dialysis; Vitamin D	2006
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2006, Volume: 16, Issue:3 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphates; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D	2006
[Progress in the treatment of secondary hyperparathyroidism. Role of calcimimetics]. Przeglad lekarski, 2006, Volume: 63 Suppl 3 Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphates; Receptors, Calcium-Sensing; Renal Dialysis	2006
Therapeutic strategies for secondary hyperparathyroidism in dialysis patients. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2006, Volume: 10, Issue:4 Topics: Calcium; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phosphates; Renal Dialysis; Vitamin D	2006
Drug Insight: renal indications of calcimimetics. Nature clinical practice. Nephrology, 2006, Volume: 2, Issue:6 Topics: Calcium; Cinacalcet; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Neoplasms; Renal Dialysis	2006
[Calcium receptor/calcium-sensing receptor]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2006, Volume: 128, Issue:3 Topics: Aniline Compounds; Binding Sites; Calcium; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Mutation; Naphthalenes; Phenethylamines; Propylamines; Receptors, Calcium-Sensing; Signal Transduction	2006
Calciphylaxis: no therapeutic concepts for a poorly understood syndrome? Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2006, Volume: 4, Issue:12 Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbaric Oxygenation; Hyperparathyroidism; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Obesity; Parathyroidectomy; Phosphates; Renal Dialysis; Risk Factors; Sex Factors; Thiosulfates; Time Factors	2006
Management of chronic kidney disease mineral-bone disorder. Advances in chronic kidney disease, 2007, Volume: 14, Issue:1 Topics: Bone Density Conservation Agents; Bone Diseases; Calcifediol; Chronic Disease; Cinacalcet; Diet; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Failure, Chronic; Minerals; Naphthalenes; Parathyroid Hormone; Phosphates; Phosphorus; Vitamin D	2007
[Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl]. Clinical calcium, 2007, Volume: 17, Issue:1 Topics: Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mutation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Receptors, Calcium-Sensing	2007
The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 2007, Volume: 11, Issue:18 Topics: Cardiovascular Diseases; Cinacalcet; Cost-Benefit Analysis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Markov Chains; Middle Aged; Models, Economic; Naphthalenes; Parathyroid Hormone; Phosphates; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D	2007
[New Active vitamin D analogs and calcimimetics to control hyperparathyroidism in chronic renal failure]. Clinical calcium, 2007, Volume: 17, Issue:5 Topics: Bone Density Conservation Agents; Cinacalcet; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Vitamin D	2007
The role of calcimimetics in the treatment of hyperparathyroidism. European journal of clinical investigation, 2007, Volume: 37, Issue:12 Topics: Adenoma; Calcium; Cinacalcet; Humans; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy	2007
[Parathyroid and bone. Calcimimetics and bone metabolism]. Clinical calcium, 2007, Volume: 17, Issue:12 Topics: Animals; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Cinacalcet; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Osteitis Fibrosa Cystica; Parathyroid Hormone; Randomized Controlled Trials as Topic; Rats; Receptors, Calcium-Sensing	2007
Recent updates on the calcium-sensing receptor as a drug target. Current medicinal chemistry, 2008, Volume: 15, Issue:2 Topics: Allosteric Regulation; Animals; Calcium; Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Osteoporosis; Parathyroid Glands; Parathyroid Hormone; Receptors, Calcium-Sensing; Receptors, GABA-B	2008
Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Calcinosis; Calcium; Chelating Agents; Cinacalcet; Coronary Artery Disease; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections; Japan; Kidney Failure, Chronic; Naphthalenes; Niacinamide; Parathyroidectomy; Phosphates; Renal Dialysis; Treatment Outcome; Vitamin D	2008
[K-DOQI guidelines for calcium and phosphorus metabolism in chronic kidney disease: outcomes, compliance and new drugs for treatment]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2007, Volume: 27, Issue:6 Topics: Calcium; Cinacalcet; Humans; Kidney Failure, Chronic; Lanthanum; Naphthalenes; Phosphorus; Polyamines; Practice Guidelines as Topic; Sevelamer; Treatment Outcome	2007
New approaches to treatment of secondary hyperparathyroidism. Current opinion in investigational drugs (London, England : 2000), 2008, Volume: 9, Issue:4 Topics: Chelating Agents; Cinacalcet; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Phosphates; Receptors, Calcium-Sensing; Treatment Outcome; Vitamin D	2008
Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease. Nature clinical practice. Nephrology, 2008, Volume: 4, Issue:7 Topics: Animals; Cinacalcet; Contraindications; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Risk Factors; Severity of Illness Index	2008
Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease. Nature clinical practice. Nephrology, 2008, Volume: 4, Issue:7 Topics: Animals; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Severity of Illness Index; Treatment Outcome	2008

Trials

68 trial(s) available for cinacalcet and Chronic Kidney Failure

Article	Year
Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023, 07-31, Volume: 38, Issue:8 Topics: Adult; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroidectomy; Peritoneal Dialysis; Prospective Studies; Quality of Life; Renal Dialysis; Renal Insufficiency, Chronic	2023
[Aortic valve replacement via J-shaped partial upper sternotomy: randomized trial, mid-term results]. Khirurgiia, 2020, Issue:7 Topics: Adult; Aged; Aortic Valve; Calcium-Regulating Hormones and Agents; Cinacalcet; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minimally Invasive Surgical Procedures; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Retrospective Studies; Sternotomy; Treatment Outcome	2020
A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism. BMC nephrology, 2021, 03-23, Volume: 22, Issue:1 Topics: Adult; Calcinosis; Calcium-Regulating Hormones and Agents; Carotid Intima-Media Thickness; Cinacalcet; Heart Ventricles; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Renal Dialysis	2021
Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study. Medicine, 2017, Volume: 96, Issue:21 Topics: Aorta; Blood Pressure; Brachial Artery; Calcimimetic Agents; Calcium; Carotid Arteries; Cinacalcet; Cross-Over Studies; Double-Blind Method; Echocardiography; Humans; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis; Treatment Failure; Vascular Stiffness; Ventricular Function	2017
Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2019, 11-01, Volume: 34, Issue:11 Topics: Angiotensins; Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Meta-Analysis as Topic; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Single Nucleotide; Prognosis; Receptor, Angiotensin, Type 1; Renal Dialysis; Survival Rate	2019
A randomized controlled trial of different serum phosphate ranges in subjects on hemodialysis. BMC nephrology, 2019, 02-04, Volume: 20, Issue:1 Topics: Aged; Cardiovascular Diseases; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Follow-Up Studies; Humans; Hydroxycholecalciferols; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Patient Acceptance of Health Care; Patient Dropouts; Phosphates; Phosphorus, Dietary; Renal Dialysis; Sepsis; Sevelamer	2019
The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism. Renal failure, 2019, Volume: 41, Issue:1 Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Severity of Illness Index; Treatment Outcome; Young Adult	2019
A prospective randomized pilot study on intermittent post-dialysis dosing of cinacalcet. International urology and nephrology, 2014, Volume: 46, Issue:1 Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Pilot Projects; Prospective Studies; Renal Dialysis; Severity of Illness Index	2014
Comparative cost analysis of management of secondary hyperparathyroidism with paricalcitol or cinacalcet with low-dose vitamin D in hemodialysis patients. Journal of medical economics, 2013, Volume: 16, Issue:9 Topics: Administration, Oral; Aged; Cinacalcet; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Ergocalciferols; Female; Follow-Up Studies; Health Care Costs; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prospective Studies; Renal Dialysis; Treatment Outcome; Vitamin D	2013
Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet. Journal of medical economics, 2013, Volume: 16, Issue:9 Topics: Adult; Algorithms; Cinacalcet; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Female; Health Care Costs; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome; United States; Vitamin D	2013
Clinical benefits of an adherence monitoring program in the management of secondary hyperparathyroidism with cinacalcet: results of a prospective randomized controlled study. BioMed research international, 2013, Volume: 2013 Topics: Calcimimetic Agents; Causality; Cinacalcet; Comorbidity; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Naphthalenes; Prevalence; Risk Factors; Switzerland; Treatment Outcome	2013
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:12 Topics: Adult; Aged; Bone Diseases, Metabolic; Calcimimetic Agents; Cinacalcet; Combined Modality Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Proportional Hazards Models; Renal Dialysis; Severity of Illness Index	2013
Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study. The Journal of heart valve disease, 2013, Volume: 22, Issue:3 Topics: Aged; Bone Density Conservation Agents; Calcinosis; Cinacalcet; Coronary Vessels; Dose-Response Relationship, Drug; Drug Monitoring; Female; Heart Valves; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Naphthalenes; Prognosis; Receptors, Calcium-Sensing; Renal Dialysis; Treatment Outcome; Vitamin D	2013
Impact of parathyroidectomy on serum FGF23 and soluble Klotho in hemodialysis patients with severe secondary hyperparathyroidism. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:4 Topics: Aged; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Klotho Proteins; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Postoperative Period; Renal Dialysis; Severity of Illness Index; Solubility	2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. Journal of the American Heart Association, 2014, Nov-17, Volume: 3, Issue:6 Topics: Atherosclerosis; Calcimimetic Agents; Cinacalcet; Death, Sudden, Cardiac; Double-Blind Method; Female; Heart Failure; Humans; Hyperparathyroidism, Secondary; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Naphthalenes; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome	2014
Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:6 Topics: Adult; Age Factors; Aged; Cinacalcet; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Proportional Hazards Models; Reference Values; Renal Dialysis; Risk Assessment; Sex Factors; Statistics, Nonparametric; Treatment Outcome	2015
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clinical journal of the American Society of Nephrology : CJASN, 2015, May-07, Volume: 10, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroidectomy; Renal Dialysis; Severity of Illness Index	2015
Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2015, Volume: 19, Issue:4 Topics: Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Organ Size; Parathyroid Glands; Parathyroid Hormone; Prognosis; Prospective Studies; Renal Dialysis; Risk Assessment; Severity of Illness Index; Time	2015
Effect of Cinacalcet and Vitamin D Analogs on Fibroblast Growth Factor-23 during the Treatment of Secondary Hyperparathyroidism. Clinical journal of the American Society of Nephrology : CJASN, 2015, Jun-05, Volume: 10, Issue:6 Topics: Aged; Australia; Biomarkers; Calcimimetic Agents; Calcium; Canada; Chi-Square Distribution; Cinacalcet; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Risk Factors; Russia; Time Factors; Treatment Outcome; United States; Vitamin D	2015
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Clinical journal of the American Society of Nephrology : CJASN, 2015, May-07, Volume: 10, Issue:5 Topics: Adult; Aged; Blood Pressure; Body Mass Index; Calcimimetic Agents; Calciphylaxis; Cinacalcet; Dyslipidemias; Female; Humans; Hyperparathyroidism, Secondary; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis; Risk Factors; Sex Factors; Vitamin K	2015
A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM). Clinical journal of the American Society of Nephrology : CJASN, 2015, Jun-05, Volume: 10, Issue:6 Topics: Aged; Aged, 80 and over; Australia; Biomarkers; Calcimimetic Agents; Canada; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Russia; Time Factors; Treatment Outcome; United States; Vitamin D	2015
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Contraindications; Denosumab; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteoclasts; Prospective Studies; RANK Ligand; Renal Dialysis	2015
Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2015, Volume: 18, Issue:8 Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Models, Econometric; Quality-Adjusted Life Years; Renal Dialysis; United States	2015
Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 2016, Volume: 20, Issue:4 Topics: Asian People; Calcimimetic Agents; China; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis	2016
Cinacalcet but not vitamin D use modulates the survival benefit associated with sevelamer in the INDEPENDENT study. Clinical nephrology, 2016, Volume: 86, Issue:9 Topics: Cinacalcet; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sevelamer; Vitamin D; Vitamins	2016
Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial. Clinical journal of the American Society of Nephrology : CJASN, 2017, 02-07, Volume: 12, Issue:2 Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Calcinosis; Cardiovascular Diseases; Cause of Death; Cinacalcet; Female; Heart Failure; Hematologic Tests; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Predictive Value of Tests; Prospective Studies; Renal Dialysis; Survival Rate	2017
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. JAMA, 2017, 01-10, Volume: 317, Issue:2 Topics: Administration, Oral; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Nausea; Parathyroid Hormone; Peptides; Renal Dialysis; Time Factors; Vomiting	2017
Efficacy of cinacalcet administered with the first meal after dialysis: the SENSOR Study. Clinical nephrology, 2008, Volume: 70, Issue:2 Topics: Administration, Oral; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Treatment Outcome	2008
Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism. American journal of nephrology, 2009, Volume: 29, Issue:3 Topics: Adult; Aged; Bone and Bones; Bone Resorption; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Treatment Outcome	2009
Change in coronary artery calcification score due to cinacalcet hydrochloride administration. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Calcinosis; Cinacalcet; Coronary Artery Disease; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Time Factors; Treatment Outcome	2008
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 53, Issue:2 Topics: Aged; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis	2009
Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:3 Topics: Adult; Aged; Cinacalcet; Cohort Studies; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Receptors, Calcium-Sensing; Renal Dialysis; Ultrasonography, Doppler, Color	2009
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet. Nephron. Clinical practice, 2009, Volume: 112, Issue:1 Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D	2009
Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism? Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2009, Volume: 13 Suppl 1 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Severity of Illness Index; Treatment Outcome	2009
Middle-term use of Cinacalcet in paediatric dialysis patients. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:1 Topics: Adolescent; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Infant; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome	2010
Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. Clinical journal of the American Society of Nephrology : CJASN, 2010, Volume: 5, Issue:1 Topics: Cinacalcet; Drug Therapy, Combination; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Single-Blind Method; Vitamin D; Vitamins	2010
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:6 Topics: Aged; Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis; Vascular Diseases; Vitamin D	2010
Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2010, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cinacalcet; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Prospective Studies; Radionuclide Imaging; Renal Dialysis; Severity of Illness Index; Time Factors; Ultrasonography	2010
Effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2010, Volume: 25, Issue:8 Topics: Calcinosis; Cinacalcet; Coronary Artery Disease; Disease Progression; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Treatment Outcome	2010
Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:6 Topics: Adult; Aged; Calcium; Cinacalcet; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Quality-Adjusted Life Years; Renal Dialysis; Treatment Outcome; United States; Vitamin D	2010
Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2010, Volume: 14, Issue:6 Topics: Aged; Cinacalcet; Drug Resistance; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Prospective Studies; Renal Dialysis; Ultrasonography	2010
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:4 Topics: Adult; Calcinosis; Cinacalcet; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prognosis; Prospective Studies; Renal Dialysis; Vitamin D; Vitamins	2011
[German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:4 Topics: Adult; Aged; Calcium Phosphates; Chelating Agents; Cinacalcet; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Vitamin D	2011
The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation, 2011, Mar-15, Volume: 91, Issue:5 Topics: Aged; Biopsy; Bone and Bones; Calcium; Cinacalcet; Creatinine; Female; Glomerular Filtration Rate; Homeostasis; Humans; Hyperparathyroidism; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Nephrocalcinosis; Parathyroid Hormone; Phosphorus; Prospective Studies	2011
[Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation]. Medicina clinica, 2012, Apr-07, Volume: 138, Issue:8 Topics: Adult; Biomarkers; Calcimimetic Agents; Cinacalcet; Collagen; Drug Administration Schedule; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Naphthalenes; Parathyroid Hormone; Peptide Fragments; Treatment Outcome	2012
A novel dose regimen of cinacalcet in the treatment of severe hyperparathyroidism in hemodialysis patients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Calcium; Chi-Square Distribution; Cinacalcet; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Prospective Studies; Renal Dialysis	2011
Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality. Blood purification, 2011, Volume: 32, Issue:2 Topics: Aged; Calcitriol; Cardiovascular Diseases; Cinacalcet; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Italy; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Odds Ratio; Prospective Studies; Renal Dialysis; Risk Factors; Survival Rate; Vitamins	2011
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:2 Topics: Aged; Analysis of Variance; Biomarkers; Cinacalcet; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Naphthalenes; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome	2012
Does cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis? Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2011, Volume: 27 Topics: Administration, Oral; Ankle Brachial Index; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Vascular Calcification; Vascular Stiffness	2011
Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols. Hemodialysis international. International Symposium on Home Hemodialysis, 2012, Volume: 16, Issue:2 Topics: Cinacalcet; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Quality of Life; Renal Dialysis; Self Report; Surveys and Questionnaires; Treatment Outcome; Vitamin D	2012
A computerized treatment algorithm trial to optimize mineral metabolism in ESRD. Clinical journal of the American Society of Nephrology : CJASN, 2012, Volume: 7, Issue:4 Topics: Aged; Algorithms; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Drug Substitution; Drug Therapy, Computer-Assisted; Female; Humans; Kidney Failure, Chronic; Longitudinal Studies; Male; Metabolic Diseases; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome; Vitamin D; Vitamins	2012
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:7 Topics: Australia; Bone Diseases; Calcimimetic Agents; Canada; Cardiovascular Diseases; Cinacalcet; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Naphthalenes; Prognosis; Renal Dialysis; Russia; Survival Rate; United States; Vitamin D	2012
A pilot study of active vitamin D administration and insulin resistance in African American patients undergoing chronic hemodialysis. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2013, Volume: 23, Issue:3 Topics: Absorptiometry, Photon; Adipokines; Biomarkers; Black or African American; Body Composition; Cardiovascular Diseases; Chronic Disease; Cinacalcet; Double-Blind Method; Endpoint Determination; Female; Glucose Clamp Technique; Humans; Hyperinsulinism; Inflammation; Insulin Resistance; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Pilot Projects; Receptors, Calcium-Sensing; Renal Dialysis; Risk Factors; Vitamin D; Vitamin D Deficiency	2013
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. The New England journal of medicine, 2012, Dec-27, Volume: 367, Issue:26 Topics: Adult; Aged; Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Odds Ratio; Parathyroid Hormone; Renal Dialysis	2012
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney international, 2003, Volume: 63, Issue:1 Topics: Adult; Aged; Calcitriol; Calcium; Calcium Channel Agonists; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Titrimetry	2003
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:3 Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Receptors, Cell Surface; Renal Dialysis; Vitamin D	2003
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. The New England journal of medicine, 2004, Apr-08, Volume: 350, Issue:15 Topics: Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis	2004
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:3 Topics: Administration, Oral; Adult; Calcium; Cinacalcet; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Renal Dialysis; Vitamin D	2005
Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:7 Topics: Aged; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Prospective Studies	2005
The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:7 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Time Factors	2005
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:10 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Time Factors	2005
Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:2 Topics: Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Calcium; Cinacalcet; Creatinine; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Prospective Studies; Quality of Life; Transplantation, Homologous; Treatment Outcome	2007
Long-term outcomes of cinacalcet and paricalcitol titration protocol for treatment of secondary hyperparathyroidism. American journal of nephrology, 2007, Volume: 27, Issue:3 Topics: Black or African American; Bone and Bones; Bone Density Conservation Agents; Cinacalcet; Drug Therapy, Combination; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes	2007
Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplantation proceedings, 2007, Volume: 39, Issue:7 Topics: Adult; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Patient Selection; Prospective Studies	2007
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism. Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Algorithms; Calcium; Chelating Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Treatment Outcome; Vitamin D	2008
Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12, Issue:2 Topics: Acid Phosphatase; Aged; Asian People; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Isoenzymes; Japan; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteocalcin; Parathyroid Hormone; Phosphorus; Renal Dialysis; Tartrate-Resistant Acid Phosphatase	2008
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clinical nephrology, 2008, Volume: 69, Issue:4 Topics: Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Double-Blind Method; Female; Fibrosis; Humans; Hyperparathyroidism, Secondary; Ilium; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Prospective Studies; Renal Dialysis	2008
The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. Journal of the American Society of Nephrology : JASN, 2002, Volume: 13, Issue:4 Topics: Administration, Oral; Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Osmolar Concentration; Parathyroid Hormone; Renal Dialysis	2002

Other Studies

148 other study(ies) available for cinacalcet and Chronic Kidney Failure

Article	Year
Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor. Endocrinology, 2012, Volume: 153, Issue:3 Topics: Allosteric Site; Aniline Compounds; Calcimimetic Agents; Calcium; Cell Membrane; Cinacalcet; HEK293 Cells; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Failure, Chronic; Ligands; Naphthalenes; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing; Signal Transduction; Treatment Outcome	2012
Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients. World journal of surgery, 2022, Volume: 46, Issue:4 Topics: Adult; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis; United States	2022
Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage. Surgery, 2022, Volume: 172, Issue:1 Topics: Adolescent; Adult; Aged; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Medicare; Middle Aged; Parathyroidectomy; Renal Dialysis; United States; Young Adult	2022
Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2023, Volume: 81, Issue:3 Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Medicare; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies; United States	2023
Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study. International urology and nephrology, 2023, Volume: 55, Issue:7 Topics: Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis	2023
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism. Jornal brasileiro de nefrologia, 2019, Jul-18, Volume: 41, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D	2019
Cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients below age 5 years . Clinical nephrology, 2019, Volume: 92, Issue:6 Topics: Calcimimetic Agents; Child, Preschool; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Infant; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Renal Dialysis; Retrospective Studies	2019
The use of cinacalcet after pediatric renal transplantation: an international CERTAIN Registry analysis. Pediatric nephrology (Berlin, Germany), 2020, Volume: 35, Issue:9 Topics: Adolescent; Calcimimetic Agents; Child; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Off-Label Use; Pilot Projects; Registries; Retrospective Studies; Transplant Recipients	2020
Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis. Surgery, 2021, Volume: 169, Issue:1 Topics: Calcimimetic Agents; Calcium; Cinacalcet; Computer Simulation; Cost-Benefit Analysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Medicare; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Quality-Adjusted Life Years; Renal Dialysis; Renal Elimination; Time-to-Treatment; United States	2021
Factors affecting the relationship between ionized and corrected calcium levels in peritoneal dialysis patients: a retrospective cross-sectional study. BMC nephrology, 2020, 08-26, Volume: 21, Issue:1 Topics: Aged; Bone Density Conservation Agents; Calcium; Calcium-Regulating Hormones and Agents; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Cross-Sectional Studies; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Retrospective Studies; Vitamin D	2020
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients. American journal of nephrology, 2020, Volume: 51, Issue:10 Topics: Aged; Calcimimetic Agents; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Peptides; Phosphates; Renal Dialysis; Retrospective Studies	2020
Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes. Transplantation, 2021, 12-01, Volume: 105, Issue:12 Topics: Adult; Aged; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Medicare; Parathyroidectomy; Renal Dialysis; United States	2021
Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States. The Journal of surgical research, 2021, Volume: 264 Topics: Administrative Claims, Healthcare; Calcimimetic Agents; Cinacalcet; Female; Hospital Mortality; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroidectomy; Postoperative Complications; Practice Guidelines as Topic; Practice Patterns, Physicians'; Referral and Consultation; United States	2021
Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease. Scientific reports, 2021, 05-11, Volume: 11, Issue:1 Topics: Aged; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; Female; Humans; Hypertrophy; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Organ Size; Parathyroid Hormone; Phosphates; Polycystic Kidney, Autosomal Dominant; Retrospective Studies	2021
Impact of calcimimetics in surgery of secondary hyperparathyroidism. Endocrinologia, diabetes y nutricion, 2017, Volume: 64, Issue:1 Topics: Adult; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroidectomy; Renal Dialysis; Retrospective Studies	2017
Mortality in dialysis patients with cinacalcet use: A large observational registry study. European journal of internal medicine, 2017, Volume: 42 Topics: Adolescent; Adult; Aged; Austria; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Registries; Renal Dialysis; Retrospective Studies; Survival Analysis; Vitamin D; Young Adult	2017
Dosing of Etelcalcetide vs Cinacalcet for Secondary Hyperparathyroidism-Reply. JAMA, 2017, 05-23, Volume: 317, Issue:20 Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis	2017
Estimating the Effect of Preventable Treatment Discontinuation on Health Outcomes. Epidemiology (Cambridge, Mass.), 2018, Volume: 29, Issue:1 Topics: Adult; Aged; Bias; Calcimimetic Agents; Cinacalcet; Deprescriptions; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Probability; Renal Dialysis	2018
The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report. BMC nephrology, 2017, Oct-18, Volume: 18, Issue:1 Topics: Adult; Calcimimetic Agents; Carcinoma; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Neoplasms; Renal Dialysis	2017
Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2018, Volume: 16, Issue:3 Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Greece; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypophosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphates; Prospective Studies; Time Factors; Treatment Outcome	2018
Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Renal failure, 2018, Volume: 40, Issue:1 Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Cross-Sectional Studies; Female; Gallstones; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prevalence; Renal Dialysis; Sex Factors; Time Factors	2018
[Dystrophic Calcinosis Cutis: a rare fearsome issue of Chronic Kidney Disease]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2018, Volume: 35, Issue:1 Topics: Calcinosis; Chelation Therapy; Cinacalcet; Female; Glomerulonephritis, Membranous; Hand Deformities, Acquired; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Phosphorus; Skin Diseases; Vitamin D	2018
The Calcium-Sensing Receptor Gene Polymorphism rs1801725 and Calcium-Related Phenotypes in Hemodialysis Patients. Kidney & blood pressure research, 2018, Volume: 43, Issue:3 Topics: Calcium; Cinacalcet; Coronary Artery Disease; Female; Humans; Hyperparathyroidism, Secondary; Infections; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phenotype; Polymorphism, Single Nucleotide; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D	2018
Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy. American journal of surgery, 2019, Volume: 217, Issue:1 Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroidectomy; Preoperative Care; Propensity Score; Renal Dialysis; Retrospective Studies; Treatment Outcome	2019
Outcomes of cinacalcet withdrawal in Australian dialysis patients. Internal medicine journal, 2019, Volume: 49, Issue:1 Topics: Aged; Alkaline Phosphatase; Australia; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis; Retrospective Studies; Withholding Treatment	2019
Cinacalcet as rescue therapy for refractory hyperparathyroidism in young children with advanced chronic kidney disease. Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:1 Topics: Calcimimetic Agents; Child; Child, Preschool; Cinacalcet; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Humans; Hyperparathyroidism, Secondary; Infant; Kidney Failure, Chronic; Male; Parathyroid Hormone; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2019
Changing landscape of the treatment of hyperparathyroidism related to end-stage renal disease-can we turn the clock backward? Surgery, 2019, Volume: 165, Issue:2 Topics: Calcimimetic Agents; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroidectomy	2019
Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics. Surgery, 2019, Volume: 165, Issue:1 Topics: Adult; Aged; Australia; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Insurance, Pharmaceutical Services; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Regression Analysis; Severity of Illness Index; Time-to-Treatment	2019
Variability in Cinacalcet Prescription across US Hemodialysis Facilities. Clinical journal of the American Society of Nephrology : CJASN, 2019, 02-07, Volume: 14, Issue:2 Topics: Age Factors; Aged; Aged, 80 and over; Ambulatory Care Facilities; Black or African American; Calcimimetic Agents; Cinacalcet; Cross-Sectional Studies; Drug Prescriptions; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Time Factors; United States	2019
Trimethylamine Clinical journal of the American Society of Nephrology : CJASN, 2019, 02-07, Volume: 14, Issue:2 Topics: Adult; Aged; Angina, Unstable; Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Female; Hospitalization; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Methylamines; Middle Aged; Mortality; Myocardial Infarction; Randomized Controlled Trials as Topic; Renal Dialysis; Stroke	2019
Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients. American journal of nephrology, 2013, Volume: 37, Issue:5 Topics: Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Receptors, Calcium-Sensing; Renal Dialysis; Up-Regulation	2013
Massive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease. Polskie Archiwum Medycyny Wewnetrznej, 2013, Volume: 123, Issue:4 Topics: Arthralgia; Calcinosis; Cinacalcet; Female; Hip; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Joint Diseases; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Palpation; Parathyroidectomy; Radiography; Recurrence; Shoulder	2013
Development of nephrolithiasis in a renal transplant patient during treatment with Cinacalcet. Annals of transplantation, 2013, Jan-22, Volume: 18 Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Humans; Hypercalciuria; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Naphthalenes; Nephrolithiasis; Tomography, X-Ray Computed	2013
Racial differences in clinical use of cinacalcet in a large population of hemodialysis patients. American journal of nephrology, 2013, Volume: 38, Issue:2 Topics: Adolescent; Adult; Aged; Black or African American; Calcimimetic Agents; Centers for Medicare and Medicaid Services, U.S.; Cinacalcet; Female; Healthcare Disparities; Humans; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Proportional Hazards Models; Quality of Health Care; Renal Dialysis; Retrospective Studies; Time Factors; Treatment Outcome; United States; Vitamin D; White People; Young Adult	2013
Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2013, Volume: 148, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biopsy; Calciphylaxis; Cinacalcet; Combined Modality Therapy; Fatal Outcome; Female; Hemodialysis Solutions; Heparin; Humans; Hyperbaric Oxygenation; Kidney Failure, Chronic; Leg Ulcer; Male; Middle Aged; Naphthalenes; Prognosis; Renal Dialysis; Skin Ulcer; Thiosulfates; Warfarin	2013
Compliance with objectives based on different guidelines (KDIGO/S.E.N.) and analysis of the individual variability of mineral metabolism in haemodialysis patients in the medium term. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2013, Volume: 33, Issue:5 Topics: Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Ergocalciferols; Female; Follow-Up Studies; Goals; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Peritoneal Dialysis; Phosphorus; Postoperative Complications; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies	2013
Bimaxillary full arch fixed dental implant supported treatment for a patient with renal failure and secondary hyperparathyroidism and osteodystrophy. The Journal of oral implantology, 2015, Volume: 41, Issue:2 Topics: Cinacalcet; Dental Implants; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone	2015
Successful treatment of calciphylaxis by a multidisciplinary approach. BMJ case reports, 2014, Jul-17, Volume: 2014 Topics: Calciphylaxis; Chelating Agents; Cinacalcet; Female; Humans; Hyperbaric Oxygenation; Kidney Failure, Chronic; Leg Ulcer; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis; Polyamines; Sevelamer; Staphylococcal Infections; Treatment Outcome	2014
Influence on quality of life from an early cinacalcet prescription for secondary hyperparathyroidism in dialysis. Pharmacoepidemiology and drug safety, 2015, Volume: 24, Issue:2 Topics: Aged; Aged, 80 and over; Bone Diseases, Metabolic; Cinacalcet; Dialysis; Drug Administration Schedule; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Quality of Life	2015
Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study. BMC nephrology, 2015, Mar-31, Volume: 16 Topics: Adult; Aged; Analysis of Variance; Cinacalcet; Cohort Studies; Databases, Factual; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Prognosis; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome; United States	2015
Evolving calciphylaxis--what randomized, controlled trials can contribute to the capture of rare diseases. Clinical journal of the American Society of Nephrology : CJASN, 2015, May-07, Volume: 10, Issue:5 Topics: Calcimimetic Agents; Calciphylaxis; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male	2015
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality. Pharmacoepidemiology and drug safety, 2015, Volume: 24, Issue:7 Topics: Adult; Aged; Bias; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Mortality; Observational Studies as Topic; Phosphorus; Propensity Score; Renal Dialysis	2015
Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol. Journal of clinical pharmacology, 2015, Volume: 55, Issue:11 Topics: Adult; Aged; Calcitriol; Cinacalcet; Drug Resistance; Ergocalciferols; Erythropoietin; Female; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Urea	2015
Administration of calcimimetics after dialysis: same effectiveness, better gastrointestinal tolerability. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2015, Volume: 35, Issue:4 Topics: Aged; Ambulatory Care; Calcimimetic Agents; Calcium; Cinacalcet; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Satisfaction; Phosphorus; Prospective Studies; Renal Dialysis; Therapeutic Equivalency; Visual Analog Scale	2015
Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis. Surgery, 2016, Volume: 159, Issue:1 Topics: Aged; Aged, 80 and over; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Prospective Studies; Renal Dialysis	2016
Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design. BMC nephrology, 2015, Oct-29, Volume: 16 Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Income; Insurance Coverage; Kidney Failure, Chronic; Male; Medicare Part D; Middle Aged; Parathyroid Hormone; Phosphorus; Public Assistance; Renal Dialysis; Retreatment; Retrospective Studies; Serum Albumin; United States; Withholding Treatment	2015
Cinacalcet-associated severe hypocalcemia resulting in torsades de pointes and cardiac arrest: a case for caution. European journal of clinical pharmacology, 2016, Volume: 72, Issue:3 Topics: Adult; Calcimimetic Agents; Cinacalcet; Heart Arrest; Humans; Hypocalcemia; Kidney Failure, Chronic; Male; Torsades de Pointes	2016
The effects of cinacalcet treatment on bone mineral metabolism, anemia parameters, left ventricular mass index and parathyroid gland volume in hemodialysis patients with severe secondary hyperparathyroidism. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2016, Volume: 27, Issue:1 Topics: Anemia; Bone Density; Calcimimetic Agents; Calcium; Cinacalcet; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Glands; Pilot Projects; Prospective Studies; Renal Dialysis	2016
Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2016, Volume: 36, Issue:2 Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis	2016
Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, 03-01, Volume: 32, Issue:3 Topics: Aged; Biomarkers; Calcimimetic Agents; Calcitriol; Calcium; Cinacalcet; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Parathyroid Hormone; Patient Care Planning; Phosphorus; Renal Dialysis; Vitamins	2017
The win ratio approach to analyzing composite outcomes: An application to the EVOLVE trial. Contemporary clinical trials, 2016, Volume: 48 Topics: Aged; Angina, Unstable; Calcimimetic Agents; Cause of Death; Cinacalcet; Female; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Randomized Controlled Trials as Topic; Treatment Outcome	2016
Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States. Clinical journal of the American Society of Nephrology : CJASN, 2016, 07-07, Volume: 11, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cinacalcet; Female; Heart Failure; Hospital Mortality; Humans; Hyperparathyroidism, Secondary; Incidence; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Length of Stay; Male; Middle Aged; Parathyroidectomy; Peripheral Vascular Diseases; Treatment Outcome; United States; Young Adult	2016
The association between cinacalcet use and missed in-center hemodialysis treatment rate. Pharmacoepidemiology and drug safety, 2016, Volume: 25, Issue:11 Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Health Status; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Vitamin D	2016
Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism. Annals of surgical oncology, 2017, Volume: 24, Issue:1 Topics: Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Netherlands; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies; Time Factors; Treatment Outcome; Vitamin D	2017
Effects of Secondary Hyperparathyroidism Treatment on Improvement in Anemia: Results from the MBD-5D Study. PloS one, 2016, Volume: 11, Issue:10 Topics: Aged; Anemia; Calcimimetic Agents; Calcitriol; Case-Control Studies; Cinacalcet; Diabetes Complications; Female; Follow-Up Studies; Glomerulonephritis; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Parathyroid Hormone; Prospective Studies; Receptors, Calcitriol; Renal Dialysis; Treatment Outcome	2016
Facial swelling in a child on chronic hemodialysis: Answers. Pediatric nephrology (Berlin, Germany), 2017, Volume: 32, Issue:8 Topics: Calcimimetic Agents; Child; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Edema; Face; Facial Bones; Humans; Kidney Failure, Chronic; Male; Osteitis Fibrosa Cystica; Renal Dialysis; Tomography, X-Ray Computed; Urogenital Abnormalities; Vesico-Ureteral Reflux	2017
Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation. Transplantation proceedings, 2016, Volume: 48, Issue:10 Topics: Adult; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Retrospective Studies	2016
Calciphylaxis of the breast: a rare disease in the differential diagnosis of breast cancer. Acta dermatovenerologica Croatica : ADC, 2008, Volume: 16, Issue:2 Topics: Breast Diseases; Breast Neoplasms; Calciphylaxis; Cinacalcet; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Mastectomy; Middle Aged; Naphthalenes; Parathyroidectomy; Treatment Outcome	2008
Adherence to K/DOQI guidelines for calcium-based phosphate binders in clinical practice. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2008, Volume: 18, Issue:4 Topics: Bone and Bones; Bone Diseases, Metabolic; Calcium; Cinacalcet; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Quality of Health Care; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D	2008
Use of cinacalcet HCl to achieve the recommended targets of bone metabolism in a patient with therapy-resistant renal hyperparathyroidism. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2008, Volume: 18, Issue:4 Topics: Adult; Bone Diseases, Metabolic; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Treatment Outcome; Weight Gain	2008
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:11 Topics: Adult; Aged; Calcium; Cinacalcet; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Tacrolimus	2008
Optimal TARGETs for cardiovascular safety and benefit in ESRD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:10 Topics: Calcium; Cardiovascular Diseases; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Safety; Sterols; Vitamin D	2008
Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Aug-01, Volume: 65, Issue:15 Topics: Adult; Aged; Calciphylaxis; Cinacalcet; Diphosphonates; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Thiosulfates	2008
Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clinical nephrology, 2008, Volume: 70, Issue:3 Topics: Aged; Calciphylaxis; Cinacalcet; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Skin Diseases, Vascular	2008
Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation, 2008, Oct-15, Volume: 86, Issue:7 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Postoperative Complications	2008
Regression of parathyroid gland swelling by treatment with cinacalcet. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:2 Topics: Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroid Glands; Renal Dialysis	2009
[Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2008, Volume: 132, Issue:5 Topics: Allosteric Regulation; Animals; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Glands; Rats; Receptors, Calcium-Sensing; Renal Dialysis	2008
19th Annual Meeting of the Japanese Society for Kidney Bone Disease. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Receptors, Calcium-Sensing	2008
Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Animals; Biomarkers; Calcium; Cinacalcet; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome	2008
Role of cinacalcet in management of mineral bone disorder in chronic kidney disease (control of calcium, phosphorus and parathyroid hormone). Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Treatment Outcome; Vitamin D	2008
Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Calcium; Cinacalcet; Cost-Benefit Analysis; Ethanol; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Glands; Parathyroidectomy; Phosphorus; Quality of Life; Survival Rate	2008
Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Aged; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Drug Therapy, Combination; Fibrosis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Osteoblasts; Parathyroid Hormone; Renal Dialysis; Time Factors; Vitamin D	2008
Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN1493 study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2008, Volume: 12 Suppl 1 Topics: Calcium; Cinacalcet; Guidelines as Topic; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Societies, Medical	2008
Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006. Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:2 Topics: Adolescent; Adult; Biomarkers; Calcium; Centers for Medicare and Medicaid Services, U.S.; Cinacalcet; Databases as Topic; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Drug Utilization Review; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Outcome and Process Assessment, Health Care; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vitamin D; Young Adult	2009
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2009, Volume: 53, Issue:2 Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Phosphorus	2009
Cinacalcet reduces vascular and soft tissue calcification in secondary hyperparathyroidism (SHPT) in hemodialysis patients. Clinical nephrology, 2009, Volume: 71, Issue:2 Topics: Adult; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Naphthalenes; Renal Dialysis	2009
Caring for chronic kidney disease patients: focus on mineral and bone disorders. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2009, Volume: 24, Issue:2 Topics: Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet Therapy; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Metabolic Diseases; Middle Aged; Naphthalenes; Parathyroid Hormone; Pharmaceutical Services; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D	2009
Cinacalcet and achievement of the NKF/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:9 Topics: Adult; Aged; Bone and Bones; Calcium; Cinacalcet; Europe; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Minerals; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D	2009
Precocious puberty and unlicensed paediatric drugs for severe hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:8 Topics: Child, Preschool; Cinacalcet; Drug Approval; Drug Labeling; Hepatocyte Nuclear Factor 1-beta; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Lanthanum; Male; Mutation; Naphthalenes; Puberty, Precocious; Testosterone; Treatment Outcome	2009
Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis? Nature reviews. Nephrology, 2009, Volume: 5, Issue:6 Topics: Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis	2009
Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder. Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:9 Topics: Biomarkers; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome; Vitamin D	2009
Emerging roles of cinacalcet hydrochloride in the management of CKD-MBD. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2009, Volume: 13 Suppl 1 Topics: Bone Diseases, Metabolic; Cinacalcet; Humans; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Terminology as Topic	2009
[Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy]. Nephrologie & therapeutique, 2010, Volume: 6, Issue:2 Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Body Mass Index; Bone Density Conservation Agents; Calcium; Chelating Agents; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Severity of Illness Index; Treatment Failure; Treatment Outcome; Vitamin D	2010
Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism. Nephron. Clinical practice, 2010, Volume: 115, Issue:3 Topics: Aged; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Organ Size; Parathyroid Glands; Prospective Studies; Renal Dialysis; Treatment Outcome; Ultrasonography	2010
Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients. Kidney international, 2010, Volume: 78, Issue:6 Topics: Calcimimetic Agents; Cardiovascular Diseases; Cinacalcet; Cohort Studies; Databases, Factual; Drug Evaluation; Humans; Kidney Failure, Chronic; Naphthalenes; Prospective Studies; Renal Dialysis; Survival Rate; Vitamin D	2010
Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis. Nutrition (Burbank, Los Angeles County, Calif.), 2010, Volume: 26, Issue:9 Topics: Aged; Anti-Inflammatory Agents; Calciphylaxis; Cinacalcet; Diphosphonates; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Pamidronate; Parathyroidectomy; Renal Dialysis; Skin; Skin Diseases	2010
The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney international, 2010, Volume: 78, Issue:12 Topics: Adolescent; Calcium; Child; Child, Preschool; Cinacalcet; Europe; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Hypocalcemia; Infant; Kidney Failure, Chronic; Latin America; Male; Naphthalenes; North America; Parathyroid Hormone; Peritoneal Dialysis; Phosphate-Binding Proteins; Phosphorus; Prospective Studies; Registries; Vitamin D; Young Adult	2010
Cinacalcet effect on severe hyperparathyroidism. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010, Volume: 21, Issue:5 Topics: Administration, Oral; Adult; Biomarkers; Calcium; Cinacalcet; Dietary Supplements; Egypt; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Severity of Illness Index; Time Factors; Treatment Outcome; Vitamin D	2010
"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study. Clinical nephrology, 2010, Volume: 74, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cinacalcet; Europe; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Prospective Studies; Renal Dialysis; Retrospective Studies; Treatment Outcome	2010
Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:6 Topics: Aged; Calcium; Cinacalcet; Cohort Studies; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Recurrence; Renal Dialysis; Survival Rate; Treatment Outcome; Vitamin D	2011
Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodialysis international. International Symposium on Home Hemodialysis, 2010, Volume: 14, Issue:4 Topics: Aged; Calcimimetic Agents; Cinacalcet; Dietary Supplements; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Prospective Studies; Renal Dialysis; Vitamin D	2010
The challenges of cost-effectiveness analyses for the clinician. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 56, Issue:6 Topics: Anemia; Cinacalcet; Cost-Benefit Analysis; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematinics; Hemoglobins; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Naphthalenes; Quality-Adjusted Life Years; Renal Dialysis; Vitamin D	2010
Cinacalcet in the treatment of hypercalcaemia and control of hyperparathyroidism due to ectopic parathyroid glands. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1 Topics: Aged, 80 and over; Calcimimetic Agents; Calcitriol; Choristoma; Cinacalcet; Female; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Mediastinal Diseases; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi	2011
Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study. Clinical nephrology, 2011, Volume: 75, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Aorta; Aortic Diseases; Biomarkers; Blood Pressure; Calcimimetic Agents; Calcium; Cinacalcet; Elasticity; Female; Humans; Hyperparathyroidism, Secondary; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Prospective Studies; Pulsatile Flow; Renal Dialysis; Spain; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left	2011
[Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study]. Nephrologie & therapeutique, 2011, Volume: 7, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Anemia, Iron-Deficiency; Biomarkers; Calcium; Calcium Phosphates; Cinacalcet; Drug Resistance; Drug Therapy, Combination; Female; Hematinics; Hemoglobins; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Phosphorus; Pilot Projects; Prospective Studies; Renal Dialysis; Treatment Outcome	2011
Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:4 Topics: Bone Diseases, Metabolic; Calcinosis; Cinacalcet; Humans; Kidney Failure, Chronic; Naphthalenes; Prognosis; Renal Dialysis; Vitamin D; Vitamins	2011
A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet. Clinical and experimental nephrology, 2011, Volume: 15, Issue:4 Topics: Anemia; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Renal Dialysis	2011
Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride. Journal of clinical pathology, 2011, Volume: 64, Issue:9 Topics: Cell Count; Cinacalcet; Drug Resistance; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Organ Size; Oxyphil Cells; Parathyroid Glands; Renal Dialysis	2011
Impact of non-traditional phosphate binders and cinacalcet on haemodialysis patient biochemistry, pill burden and cost. Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:8 Topics: Administration, Oral; Aged; Aged, 80 and over; Aluminum Hydroxide; Australia; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Costs; Female; Health Care Costs; Hemodialysis Units, Hospital; Humans; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer	2011
Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease. Clinical nephrology, 2011, Volume: 76, Issue:2 Topics: Anemia; Cinacalcet; Cohort Studies; Darbepoetin alfa; Drug Interactions; Erythropoietin; Female; Hematinics; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome	2011
Calciphylaxis: a severe complication of renal disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2011, Nov-08, Volume: 183, Issue:16 Topics: Adrenal Cortex Hormones; Calciphylaxis; Chelating Agents; Cinacalcet; Humans; Ischemia; Kidney Failure, Chronic; Liver Diseases; Naphthalenes; Obesity; Parathyroid Hormone; Risk Factors; Serum Albumin; Sex Factors; Thiosulfates; White People	2011
Multi-intervention management of calciphylaxis: a report of 7 cases. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011, Volume: 58, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Arterioles; Calciphylaxis; Chelating Agents; Cinacalcet; Combined Modality Therapy; Female; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Oxygen Inhalation Therapy; Polyamines; Renal Dialysis; Sevelamer; Thiosulfates	2011
Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism. Clinical nephrology, 2011, Volume: 76, Issue:4 Topics: Absorptiometry, Photon; Analysis of Variance; Bone Density; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Radius; Renal Dialysis; Treatment Outcome	2011
Regression of vascular calcification in a patient treated with cinacalcet: a case report. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:5 Topics: Breast; Calcimimetic Agents; Calcitriol; Calcium Carbonate; Chelating Agents; Cinacalcet; Drug Therapy, Combination; Female; Graft Rejection; Hand; Humans; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mammography; Middle Aged; Naphthalenes; Nephritis, Interstitial; Phosphorus; Polyamines; Renal Dialysis; Reoperation; Sevelamer; Vascular Calcification	2011
Multidisciplinary treatment. A therapeutic option to treat calciphylaxis. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:5 Topics: Anti-Bacterial Agents; Antiphospholipid Syndrome; Calciphylaxis; Carcinoma, Renal Cell; Cardiovascular Diseases; Cinacalcet; Clostridium Infections; Clostridium perfringens; Combined Modality Therapy; Debridement; Foot Ulcer; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Postoperative Complications; Renal Replacement Therapy; Staphylococcal Infections; Thiosulfates	2011
Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:6 Topics: Animals; Calcium; Cell Proliferation; Cinacalcet; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia	2012
Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012, Volume: 60, Issue:2 Topics: Aged; Cinacalcet; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Humans; Hyperparathyroidism, Secondary; Japan; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Monte Carlo Method; Naphthalenes; Parathyroidectomy; Quality-Adjusted Life Years; Renal Dialysis	2012
Deal watch: Amgen builds secondary hyperparathyroidism [corrected] pipeline. Nature reviews. Drug discovery, 2012, Jun-01, Volume: 11, Issue:6 Topics: Cinacalcet; Drug Industry; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Receptors, Calcium-Sensing; Renal Dialysis	2012
Maximal conservative therapy of calcific uremic ateriolopathy. Clinical nephrology, 2012, Volume: 78, Issue:1 Topics: Arterioles; Calcimimetic Agents; Chelating Agents; Cinacalcet; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperbaric Oxygenation; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Negative-Pressure Wound Therapy; Renal Dialysis; Thiosulfates; Treatment Outcome; Uremia; Vascular Calcification	2012
Asymptomatic polyostotic Paget's disease associated with secondary hyperparathyroidism in a peritoneal dialysis patient. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, Jul-17, Volume: 32, Issue:4 Topics: Aged; Alkaline Phosphatase; Arthritis, Gouty; Asymptomatic Diseases; Bone Resorption; Calcifediol; Cinacalcet; Contraindications; Diphosphonates; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Failure, Chronic; Male; Naphthalenes; Osteitis Deformans; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Radionuclide Imaging	2012
[Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients in real-world clinical practice - the ECHO observational study: French experience]. Nephrologie & therapeutique, 2012, Volume: 8, Issue:7 Topics: Aged; Calcimimetic Agents; Chelating Agents; Cinacalcet; Female; France; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Polyamines; Prospective Studies; Renal Dialysis; Retrospective Studies; Sevelamer; Vitamin D; Vitamins	2012
Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Transplantation proceedings, 2012, Volume: 44, Issue:8 Topics: Adult; Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Creatinine; Drug Administration Schedule; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Time Factors; Treatment Outcome	2012
Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic hemodialysis patient. Hemodialysis international. International Symposium on Home Hemodialysis, 2013, Volume: 17, Issue:3 Topics: Calcinosis; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroidectomy; Renal Dialysis	2013
Trials in kidney disease--time to EVOLVE. The New England journal of medicine, 2012, Dec-27, Volume: 367, Issue:26 Topics: Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Naphthalenes; Renal Dialysis	2012
Symmetrical craniofacial hypertrophy in patients with tertiary hyperparathyroidism and high-dose cinacalcet exposure. Hemodialysis international. International Symposium on Home Hemodialysis, 2012, Volume: 16, Issue:4 Topics: Adolescent; Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypertrophy; Kidney Failure, Chronic; Male; Maxillary Sinus; Naphthalenes; Parathyroidectomy; Renal Dialysis	2012
[The influence of side effects related to cinacalcet therapy on compliance in hemodialysis patients suffering from secondary hyperparathyroidism]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:3 Topics: Administration, Oral; Adult; Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Muscle Weakness; Naphthalenes; Parathyroid Hormone; Paresthesia; Patient Compliance; Renal Dialysis	2012
Fooling the parathyroid gland--will there be health benefits? The New England journal of medicine, 2004, Apr-08, Volume: 350, Issue:15 Topics: Calcium; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D	2004
The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis. British journal of clinical pharmacology, 2004, Volume: 57, Issue:6 Topics: Administration, Oral; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Renal Dialysis	2004
Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients. The New England journal of medicine, 2004, Jul-08, Volume: 351, Issue:2 Topics: Bone Remodeling; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Predictive Value of Tests; Renal Dialysis; Treatment Outcome	2004
Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients. The New England journal of medicine, 2004, Jul-08, Volume: 351, Issue:2 Topics: Calcium; Cinacalcet; Drug Administration Schedule; Heart Rate; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis	2004
Clinical experience with cinacalcet HCl. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19 Suppl 5 Topics: Alkaline Phosphatase; Cinacalcet; Clinical Trials, Phase III as Topic; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Glands; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis	2004
Cinacalcet hydrochloride: a viewpoint by Pablo Ureña Torres. Drugs, 2005, Volume: 65, Issue:2 Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Vitamin D	2005
Cinacalcet hydrochloride: a viewpoint by Sharon M. Moe. Drugs, 2005, Volume: 65, Issue:2 Topics: Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes	2005
Challenges in the therapy of secondary hyperparathyroidism. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2005, Volume: 9, Issue:1 Topics: Bone and Bones; Bone Density; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Phosphate-Binding Proteins; Phosphates; Practice Guidelines as Topic; Renal Dialysis; Risk Factors; Vitamin D; Vitamin D Deficiency	2005
Calcium-sensing receptor gene polymorphism Arg990Gly and its possible effect on response to cinacalcet HCl. Pharmacogenetics and genomics, 2005, Volume: 15, Issue:1 Topics: Adult; Aged; Alleles; Arginine; Base Sequence; Calcium; Cinacalcet; Clinical Trials as Topic; DNA; Exons; Female; Genotype; Glycine; Homozygote; Humans; Kidney Failure, Chronic; Lymphocytes; Male; Middle Aged; Models, Statistical; Molecular Sequence Data; Naphthalenes; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Receptors, Calcium-Sensing; Sequence Analysis, DNA; Time Factors	2005
Immunosuppressive and calcimimetic drug-drug interactions. Kidney international, 2005, Volume: 68, Issue:4 Topics: Cinacalcet; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Naphthalenes	2005
Successful treatment of calciphylaxis with cinacalcet-an alternative to parathyroidectomy? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:7 Topics: Calciphylaxis; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Peritoneal Dialysis; Skin Ulcer; Treatment Outcome	2006
Does cinacalcet safely and effectively maintain long-term PTH control in secondary hyperparathyroidism? Nature clinical practice. Nephrology, 2006, Volume: 2, Issue:5 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Receptors, Calcium-Sensing; Time Factors; Vitamin D	2006
Emerging strategies for lowering serum phosphorous in patients with end-stage renal disease. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:14 Topics: Adult; Cinacalcet; Humans; Kidney Failure, Chronic; Naphthalenes; Phosphate-Binding Proteins; Phosphorus; Polyamines; Renal Dialysis; Sevelamer	2006
Achieving targets for bone and mineral metabolism: the impact of cinacalcet HCl in clinical practice. Hemodialysis international. International Symposium on Home Hemodialysis, 2006, Volume: 10 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome	2006
Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:2 Topics: Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Renal Dialysis; Time Factors	2007
Cinacalcet as an adjunct in the successful treatment of calciphylaxis. The British journal of dermatology, 2006, Volume: 155, Issue:6 Topics: Adult; Biopsy; Calciphylaxis; Cinacalcet; Humans; Kidney Failure, Chronic; Male; Naphthalenes; Skin Diseases	2006
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:5 Topics: Cinacalcet; Cost-Benefit Analysis; Diet Therapy; Drug Costs; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Markov Chains; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphate-Binding Proteins; Quality-Adjusted Life Years; United Kingdom; Vitamin D	2007
Successful use of cinacalcet HCl in a patient with end-stage renal failure and refractory secondary hyperparathyroidism due to parathyromatosis. Clinical nephrology, 2007, Volume: 67, Issue:3 Topics: Aged; Calcium; Choristoma; Cinacalcet; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Radionuclide Imaging; Radiopharmaceuticals; Reoperation; Retrospective Studies; Technetium Tc 99m Sestamibi; Thoracic Surgery, Video-Assisted; Thyroid Diseases; Tomography, X-Ray Computed	2007
Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Cinacalcet; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Renal Dialysis	2007
[Reader's letter on Marcus Meissner, Jens, Gille, Roland Kaufmann. Calciphylaxis: no therapeutic concepts for a poorly understood syndrome?]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2007, Volume: 5, Issue:5 Topics: Age Factors; Calciphylaxis; Calcium; Cinacalcet; Diabetes Mellitus, Type 2; Female; Humans; Hyperbaric Oxygenation; Hyperparathyroidism; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Obesity; Parathyroidectomy; Phosphates; Renal Dialysis; Risk Factors; Sex Factors; Thiosulfates; Time Factors	2007
Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Calcium; Cardiomyopathies; Cardiotonic Agents; Cinacalcet; Drug Administration Schedule; Heart Failure; Hemofiltration; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Probability; Shock, Cardiogenic	2007
Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2007, Volume: 49, Issue:6 Topics: Adult; Cinacalcet; Cost-Benefit Analysis; Decision Trees; Female; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Quality-Adjusted Life Years; Time Factors; United States	2007
Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient. The American journal of medicine, 2007, Volume: 120, Issue:9 Topics: Calcium; Cinacalcet; Creatinine; Female; Humans; Hyperparathyroidism; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Middle Aged; Naphthalenes; Nephrocalcinosis; Parathyroid Hormone	2007
Cost-utility analysis of cinacalcet in addition to standard of care in the UK. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11 Topics: Cinacalcet; Cost-Benefit Analysis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; United Kingdom	2007
Proximal calciphylaxis treated with calcimimetic 'Cinacalcet'. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:1 Topics: Abdomen; Aged; Calciphylaxis; Cinacalcet; Fatal Outcome; Female; Hip; Humans; Kidney Failure, Chronic; Naphthalenes	2008
Effects of cinacalcet on gastrointestinal hormone release in patients with secondary hyperparathyroidism undergoing dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:4 Topics: Calcium; Cinacalcet; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastrointestinal Hormones; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Radioimmunoassay; Renal Dialysis; Severity of Illness Index; Substance P; Treatment Outcome; Vasoactive Intestinal Peptide	2008
Cinacalcet, fetuin-A and interleukin-6. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:4 Topics: alpha-2-HS-Glycoprotein; Blood Proteins; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Interleukin-6; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Treatment Outcome	2008
Cinacalcet: benefit and cost. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:4 Topics: Cinacalcet; Cost-Benefit Analysis; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Renal Dialysis	2008
[Treatment of secondary hyperparathyroidism in dialysis: Report of a case-study of treatment failure]. Nephrologie & therapeutique, 2008, Volume: 4, Issue:1 Topics: Adult; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis; Treatment Refusal	2008
Cinacalcet as first-line treatment for calciphylaxis. Acta dermato-venereologica, 2008, Volume: 88, Issue:1 Topics: Aged; Calciphylaxis; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Receptors, Calcium-Sensing; Skin Ulcer	2008
Cinacalcet improves bone mineral density in a renal transplant recipient with persistent hyperparathyroidism. Clinical nephrology, 2008, Volume: 69, Issue:3 Topics: Absorptiometry, Photon; Bone Density; Cinacalcet; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Naphthalenes	2008
Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease. Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:10 Topics: Adolescent; Adult; Calcium; Child; Child, Preschool; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Infant; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus	2008